WRF
TXG icon

Waddell & Reed Financial’s 10x Genomics TXG Stock Holding History

Waddell & Reed Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$89M Buy
491,857
+127,078
+35% +$21.9M 0.18% 156
2020
Q4 		$51.7M Sell
364,779
-642
-0.2% -$93.2K 0.11% 223
2020
Q3 		$45.6M Sell
365,421
-3,771
-1% -$396K 0.11% 213
2020
Q2 		$33M Buy
369,192
+556
+0.2% +$43.3K 0.09% 253
2020
Q1 		$23M Buy
368,636
+249,583
+210% +$19.5M 0.07% 268
2019
Q4 		$9.08M Sell
119,053
-5,898
-5% -$355K 0.02% 397
2019
Q3 		$6.3M Buy
+124,951
New +$6.91M 0.02% 411

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return